FDA Approves Agile Therapeutics, Inc.’s Twirla® (levonorgestrel and ethinyl estradiol) Transdermal System – A New Weekly Contraceptive Patch Delivering a 30 mcg Daily Dose of Estrogen and 120 mcg Daily Dose of Progestin

    NEXT STORY
    Novartis receives EC Approval for Beovu®, a next-generation anti-VEGF treatment for wet AMD, a leading cause of blindness worldwide
    PREV STORY
    Teleflex Incorporated Announces Worldwide Voluntary Recall of COMFORT FLO® Humidification System
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    BeyondSpring Provides Operational Update and First Quarter 2019 Financial Results

    author_avatar
    NASDAQ Market News

    GeoVax Awarded NIH Fast Track Phase I/II Grant to Advance Lassa Fever Vaccine

    author_avatar
    NASDAQ Market News

    Square 1 Bank Announces Credit Facility to Recursion Pharmaceuticals

    SAN DIEGO, June 05, 2018 (GLOBE NEWSWIRE) -- Square 1 Bank, a division of ...

    author_avatar
    NASDAQ Market News